---
figid: PMC9664149__fnut-09-1007816-g006
figtitle: 'Glutathione: A Samsonian life-sustaining small molecule that protects against
  oxidative stress, ageing and damaging inflammation'
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC9664149
filename: fnut-09-1007816-g006.jpg
figlink: /pmc/articles/PMC9664149/figure/F6/
number: F6
caption: 'Oxidative stress, reduced glutathione (GSH) and lung diseases. (1) Lung
  diseases affect alveolar cells increasing reactive oxygen species (ROS) production,
  reduce Kelch-like ECH-associated protein 1 (Keap1)-Nuclear factor erythroid 2-related
  factor 2 (Nrf2)-antioxidant response element (ARE) redox regulator pathway and become
  defective for surfactant production. Damaged/apoptotic cells cause alveolar cell
  activation of nuclear factor (NF)-κB and release cytokines like interleukin (IL)-8.
  Alveolar type I cells augment ROS production via toll-like receptors (TLRs) 1 and
  2. Inflammation enhances neutrophil extracellular trap (NET) release and increases
  ROS production. (2) Inflammation associated to lung diseases augments macrophage’s
  ROS production, inhibiting Nrf2 activation and enhancing NF-κB upregulation. ROS
  are counterbalanced by enzymes like superoxide dismutase (SOD), catalase (Cat),
  glutathione S-transferase (GST), and glutathione peroxidase (GPx) to protect cells
  from oxidative damage caused by nicotinamide adenine-dinucleotide phosphate (NADPH)
  oxidase 2 (NOX2), superoxide (O2–), hydrogen peroxide (H2O2), and myeloperoxidase
  (MPO). Capillary neutrophils migrate to and from alveoli by trans-endothelial (TEM)
  and reverse transmigration (rTEM), respectively. Inflammation can cause excessive
  ROS production in capillaries, red blood cell (RBC) dysfunction, thrombosis and
  alveolar damage. (3) Activated alveolar macrophages release increased levels of
  IL-1β, IL-6, IL-8, and tumor necrosis factor (TNF)-α. Inflammation-associated activated
  macrophages (via TLRs) reduce enzymes like SOD and Cat, among others, and activate
  NF-κB. NOX2 activation increases ROS production that enhance NF-κB activation. Glutathione
  (GSH) precursors (Cystine, cysteine, N-acetyl cysteine, NAC), and selenium (Se)
  restore GSH and GPx, respectively, to counteract the effects of ROS. (4) Alveolar
  macrophages engulf microbes and apoptotic cells via Fc (γ/α/μ) and scavenger receptors
  and/or pattern recognition protein receptors (PRPRs) leading to increased ROS production
  and cytokine release. MPO, nitric oxide (NO), O2–, and H2O2 through the Fenton and
  Haber-Weiss reactions that generate hydroxyl radicals, participate in ROS and RNS
  generation. Lung disease-associated inflammation and apoptosis [via TLRs and glycosaminoglycans
  (GAGs)] enhance alveolar cell ROS production that via p38MAPK, NF- κB, and AP-1
  activation, contribute to epithelial injury and further inflammation. (5) Neutrophils
  contribute to O2– production, lipid peroxidation and increased oxidative stress
  to promote a cytokine storm (). Administration of GSH precursors [cystine, cysteine,
  NAC; see (3), (4), and (5)] facilitate GSH formation to reduce oxidative stress.
  Abbreviations: PRRs, pattern recognition receptors; ɣ-GCS, ɣ-glutamyl cysteine synthetase;
  DAMPs, damage associated molecular patterns; Prxs, peroxiredoxins; NAC, N-acetyl
  cysteine; ɣ-GT, ɣ-glutamyl transpeptidase; PAMPs, pathogen associated molecular
  patterns; LPC, lysophosphatidylcholine.'
papertitle: 'Glutathione: A Samsonian life-sustaining small molecule that protects
  against oxidative stress, ageing and damaging inflammation.'
reftext: Carlos A. Labarrere, et al. Front Nutr. 2022;9:1007816.
year: '2022'
doi: 10.3389/fnut.2022.1007816
journal_title: Frontiers in Nutrition
journal_nlm_ta: Front Nutr
publisher_name: Frontiers Media S.A.
keywords: glutathione | oxidative stress | reactive oxygen species | nuclear factor
  erythroid 2-related factor 2 | inflammaging | chronic obstructive pulmonary disease
  | atherosclerosis | COVID-19
automl_pathway: 0.5346051
figid_alias: PMC9664149__F6
figtype: Figure
redirect_from: /figures/PMC9664149__F6
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9664149__fnut-09-1007816-g006.html
  '@type': Dataset
  description: 'Oxidative stress, reduced glutathione (GSH) and lung diseases. (1)
    Lung diseases affect alveolar cells increasing reactive oxygen species (ROS) production,
    reduce Kelch-like ECH-associated protein 1 (Keap1)-Nuclear factor erythroid 2-related
    factor 2 (Nrf2)-antioxidant response element (ARE) redox regulator pathway and
    become defective for surfactant production. Damaged/apoptotic cells cause alveolar
    cell activation of nuclear factor (NF)-κB and release cytokines like interleukin
    (IL)-8. Alveolar type I cells augment ROS production via toll-like receptors (TLRs)
    1 and 2. Inflammation enhances neutrophil extracellular trap (NET) release and
    increases ROS production. (2) Inflammation associated to lung diseases augments
    macrophage’s ROS production, inhibiting Nrf2 activation and enhancing NF-κB upregulation.
    ROS are counterbalanced by enzymes like superoxide dismutase (SOD), catalase (Cat),
    glutathione S-transferase (GST), and glutathione peroxidase (GPx) to protect cells
    from oxidative damage caused by nicotinamide adenine-dinucleotide phosphate (NADPH)
    oxidase 2 (NOX2), superoxide (O2–), hydrogen peroxide (H2O2), and myeloperoxidase
    (MPO). Capillary neutrophils migrate to and from alveoli by trans-endothelial
    (TEM) and reverse transmigration (rTEM), respectively. Inflammation can cause
    excessive ROS production in capillaries, red blood cell (RBC) dysfunction, thrombosis
    and alveolar damage. (3) Activated alveolar macrophages release increased levels
    of IL-1β, IL-6, IL-8, and tumor necrosis factor (TNF)-α. Inflammation-associated
    activated macrophages (via TLRs) reduce enzymes like SOD and Cat, among others,
    and activate NF-κB. NOX2 activation increases ROS production that enhance NF-κB
    activation. Glutathione (GSH) precursors (Cystine, cysteine, N-acetyl cysteine,
    NAC), and selenium (Se) restore GSH and GPx, respectively, to counteract the effects
    of ROS. (4) Alveolar macrophages engulf microbes and apoptotic cells via Fc (γ/α/μ)
    and scavenger receptors and/or pattern recognition protein receptors (PRPRs) leading
    to increased ROS production and cytokine release. MPO, nitric oxide (NO), O2–,
    and H2O2 through the Fenton and Haber-Weiss reactions that generate hydroxyl radicals,
    participate in ROS and RNS generation. Lung disease-associated inflammation and
    apoptosis [via TLRs and glycosaminoglycans (GAGs)] enhance alveolar cell ROS production
    that via p38MAPK, NF- κB, and AP-1 activation, contribute to epithelial injury
    and further inflammation. (5) Neutrophils contribute to O2– production, lipid
    peroxidation and increased oxidative stress to promote a cytokine storm (). Administration
    of GSH precursors [cystine, cysteine, NAC; see (3), (4), and (5)] facilitate GSH
    formation to reduce oxidative stress. Abbreviations: PRRs, pattern recognition
    receptors; ɣ-GCS, ɣ-glutamyl cysteine synthetase; DAMPs, damage associated molecular
    patterns; Prxs, peroxiredoxins; NAC, N-acetyl cysteine; ɣ-GT, ɣ-glutamyl transpeptidase;
    PAMPs, pathogen associated molecular patterns; LPC, lysophosphatidylcholine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - red
  - trc
  - Cat
  - Ca-alpha1T
  - ChAT
  - sv
  - gp
  - GstS1
  - GstE12
  - GstD1
  - GstD2
  - GstD3
  - GstD4
  - GstD5
  - GstD6
  - GstD7
  - GstD8
  - Gclc
  - Dif
  - dl
  - Rel
  - nac
  - Nacalpha
  - se
  - 18w
  - tok
  - tlr-2
  - mmy
  - noi
  - Toll-4
  - pns
  - net
  - Neto
  - NetA
  - NetB
  - Amph
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - egr
  - crp
  - Drs
  - ke
  - Ste12DOR
  - obe
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Nap1
  - Hem
  - FGA
  - FGB
  - FGG
  - IK
  - DYRK3
  - MPO
  - CYLD
  - TNMD
  - MFT2
  - CAT
  - CRAT
  - GLYAT
  - SLCO6A1
  - GSTK1
  - GSTA1
  - GSTA2
  - GSTA3
  - GSTA4
  - GSTA5
  - GSTM1
  - GSTM2
  - GSTM3
  - GSTM4
  - GSTM5
  - GSTO1
  - GSTO2
  - GSTP1
  - GSTT1
  - GSTT2
  - GSTZ1
  - GSTT2B
  - RN7SL263P
  - CYBB
  - GCLC
  - UGCG
  - NOG
  - RUSF1
  - LINC01322
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - XK
  - NLRP1
  - TGFB1
  - IFT122
  - GPX1
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - COPD
  - ARCN1
  - SPINK5
  - LINC00689
  - NCF2
  - NCF4
  - ELK3
  - EPHB1
  - SLC6A2
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - CYBA
  - IL6
  - IL13
  - CXCL8
  - TNF
  - CRP
  - CSRP1
  - PPIAP10
  - SULT1E1
  - ERVK-8
  - ERVK-10
  - ERVK-9
  - ERVK-21
  - ERVK-18
  - ERVK-25
  - ERVK-24
  - ERVK-19
  - NAP1L1
  - NAPSA
  - ACOT8
  - NCKAP1
  - TRMO
  - AZI2
  - NAA25
  - TAB3
  - Selenium
  - Cystine
  - Cysteine
  - NAC
  - Se
  - GSH
  - thrombosis
  - Thrombosis
  - Alveolardamage
  - COPD
  - respiratory infections
  - fibrosis
  - asthma
  - Birth asphyxia
  - trauma
  - alveolar opithella
---
